Treatment Regimens for Mifegyne and Cytotec

Western Galilee Hospital-Nahariya

Status and phase: Unknown; Phase 3

Conditions: Medical Abortion

Treatments: Drug: mifegyne and cytotec

Study type: Interventional

Funder types: Other

Identifiers

NCT00920465

4-10-2007

Details and patient eligibility

About

The purpose of this study is to test two regimens of mifegyne and cytotec for medical abortion. The investigators hypothesize that administration of both medications during one hospital visit will not compromise effectiveness.

Enrollment: 200 estimated patients

Sex: Female

Ages: 18 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• above age 18,
• for whom Mifegyne and cytotec are indicated.

Exclusion criteria

• inflammation of oral cavity.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

200 participants in 2 patient groups

one-visit

Experimental group

Treatment:

Drug: mifegyne and cytotec

two-visit

Active Comparator group

Treatment:

Drug: mifegyne and cytotec